Pharmacokinetic Drug Interactions of New Antidepressants: A Review of the Effects on the Metabolism of Other Drugs
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 72 (9) , 835-847
- https://doi.org/10.4065/72.9.835
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Effect of Sertraline on Protein Binding of WarfarinClinical Pharmacokinetics, 1997
- A Study of the Potential Effect of Sertraline on the Pharmacokinetics and Protein Binding of TolbutamideClinical Pharmacokinetics, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- “It's the genes, stupid” Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphismLife Sciences, 1995
- Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and DiazepamThe Journal of Clinical Pharmacology, 1995
- Increased trimipramine plasma levels during fluvoxamine comedicationEuropean Neuropsychopharmacology, 1994
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old BoyDrug Safety, 1991
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984